The role of the human RECK protein in modifying human sarcoma progression within in vitro and in vivo models

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/558423

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The protein “RECK” is known to have a controlling effect on cancers by reducing growth, invasion, and blood supply. RECK is present in normal tissues but in bone and soft-tissue tumours (sarcomas), the protein is reduced. This study aims to; correlate RECK levels in sarcoma with patient survival, use gene technology to increase RECK levels in sarcoma cells, and observe the effects on sarcoma invasion and metastasis.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2009

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $34,878.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

RECK | angiogenesis | matrix metalloproteinase

Related Links